- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Enovix Receives 'Hold' Rating from Analysts
Lithium-ion battery maker Enovix sees mixed analyst reviews as it scales up manufacturing capacity.
Mar. 27, 2026 at 8:33am
Got story updates? Submit your updates here. ›
Enovix Corporation, a developer of advanced lithium-ion battery cells, has received a consensus 'Hold' rating from 11 brokerages currently covering the firm. The ratings include one 'Sell', four 'Hold', and six 'Buy' recommendations, with an average 12-month price target of $13.46.
Why it matters
Enovix's patented 3D silicon-anode architecture aims to deliver higher energy density, improved safety, and longer cycle life compared to conventional lithium-ion batteries. As the company scales up manufacturing to meet growing demand, the mixed analyst reviews reflect the challenges and opportunities it faces in the competitive battery technology market.
The details
The 'Hold' rating comes as Enovix works to ramp up production capacity for its advanced lithium-ion battery cells. Analysts have cited concerns over the company's near-term outlook, with one issuing a 'Sell' rating and others maintaining 'Hold' recommendations. However, a majority of analysts covering Enovix have assigned 'Buy' ratings, reflecting confidence in the company's long-term potential.
- Enovix was founded in 2011 and is headquartered in Fremont, California.
- The company's average 12-month price target is $13.46 as of the latest analyst coverage.
The players
Enovix Corporation
A developer of advanced lithium-ion battery cells with a patented 3D silicon-anode architecture, targeting applications in consumer electronics, wearables, electric vehicles, and energy storage.
Weiss Ratings
A research firm that has issued a 'sell (d-)' rating on Enovix shares.
Canaccord Genuity Group
An investment bank that has cut its price target on Enovix from $21 to $15, maintaining a 'Buy' rating.
Bank of America
A financial services firm that has assumed coverage of Enovix with a 'Neutral' rating and $6 price target.
Oppenheimer
An investment bank that has reiterated an 'Outperform' rating on Enovix.
What they’re saying
“We must not let individuals continue to damage private property in San Francisco.”
— Robert Jenkins, San Francisco resident
“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”
— Gordon Edgar, grocery employee
The takeaway
As Enovix scales its innovative battery technology, the mixed analyst views highlight the challenges of navigating the competitive landscape and meeting the high expectations of the market. The company's long-term potential remains promising, but its near-term outlook will be closely watched as it ramps up manufacturing capacity.
